Literature DB >> 20008199

Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Gordon D McLaren1, Victor R Gordeuk.   

Abstract

Hemochromatosis comprises a group of inherited disorders resulting from mutations of genes involved in regulating iron metabolism. The multicenter, multi-ethnic Hemochromatosis and Iron Overload Screening (HEIRS) Study screened approximately 100,000 participants in the US and Canada, testing for HFE mutations, serum ferritin and transferrin saturation. As in other studies, HFE C282Y homozygosity was common in Caucasians but rare in other ethnic groups, and there was a marked heterogeneity of disease expression in C282Y homozygotes. Nevertheless, this genotype was often associated with elevations of serum ferritin and transferrin saturation and with iron stores of more than four grams in men but not in women. If liver biopsy was performed, in some cases because of evidence of hepatic dysfunction, fibrosis or cirrhosis was often found. Combined elevations of serum ferritin and transferrin saturation were observed in non-C282Y homozygotes of all ethnic groups, most prominently Asians, but not often with iron stores of more than four grams. Future studies to discover modifier genes that affect phenotypic expression in C282Y hemochromatosis should help identify patients who are at greatest risk of developing iron overload and who may benefit from continued monitoring of iron status to detect progressive iron loading.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008199      PMCID: PMC3829617          DOI: 10.1182/asheducation-2009.1.195

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  78 in total

1.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Prevalence of hereditary hemochromatosis in 16031 primary care patients.

Authors:  P D Phatak; R L Sham; R F Raubertas; K Dunnigan; M T O'Leary; C Braggins; J D Cappuccio
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  Reticuloendothelial iron stores and hereditary hemochromatosis: a paradox.

Authors:  G D McLaren
Journal:  J Lab Clin Med       Date:  1989-02

5.  Multicentric origin of hemochromatosis gene (HFE) mutations.

Authors:  J Rochette; J J Pointon; C A Fisher; G Perera; M Arambepola; D S Arichchi; S De Silva; J L Vandwalle; J P Monti; J M Old; A T Merryweather-Clarke; D J Weatherall; K J Robson
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

Review 6.  Etiologies, consequences, and treatment of iron overload.

Authors:  V R Gordeuk; G D McLaren; W Samowitz
Journal:  Crit Rev Clin Lab Sci       Date:  1994       Impact factor: 6.250

7.  Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis.

Authors:  G D McLaren; M H Nathanson; A Jacobs; D Trevett; W Thomson
Journal:  J Lab Clin Med       Date:  1991-05

8.  Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation.

Authors:  G Fillet; Y Beguin; L Baldelli
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

Review 9.  Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis.

Authors:  D L Witte; W H Crosby; C Q Edwards; V F Fairbanks; F A Mitros
Journal:  Clin Chim Acta       Date:  1996-02-28       Impact factor: 3.786

10.  Long-term survival in patients with hereditary hemochromatosis.

Authors:  C Niederau; R Fischer; A Pürschel; W Stremmel; D Häussinger; G Strohmeyer
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  18 in total

Review 1.  Genome-wide association studies and genetic risk assessment of liver diseases.

Authors:  Marcin Krawczyk; Roman Müllenbach; Susanne N Weber; Vincent Zimmer; Frank Lammert
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

2.  Genome-wide association study of iron traits and relation to diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL): potential genomic intersection of iron and glucose regulation?

Authors:  Laura M Raffield; Tin Louie; Tamar Sofer; Deepti Jain; Eli Ipp; Kent D Taylor; George J Papanicolaou; Larissa Avilés-Santa; Leslie A Lange; Cathy C Laurie; Matthew P Conomos; Timothy A Thornton; Yii-Der Ida Chen; Qibin Qi; Scott Cotler; Bharat Thyagarajan; Neil Schneiderman; Jerome I Rotter; Alex P Reiner; Henry J Lin
Journal:  Hum Mol Genet       Date:  2017-05-15       Impact factor: 6.150

3.  Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes.

Authors:  Hiroshi Kawabata; Kensuke Usuki; Maki Shindo-Ueda; Junya Kanda; Kaoru Tohyama; Akira Matsuda; Kayano Araseki; Tomoko Hata; Takahiro Suzuki; Hidekazu Kayano; Kei Shimbo; Shigeru Chiba; Takayuki Ishikawa; Nobuyoshi Arima; Masaharu Nohgawa; Yasushi Miyazaki; Mineo Kurokawa; Shunya Arai; Kinuko Mitani; Akifumi Takaori-Kondo
Journal:  Int J Hematol       Date:  2019-07-29       Impact factor: 2.490

4.  Effect of the Hemochromatosis Mutations on Iron Overload among the Indian β Thalassemia Carriers.

Authors:  Anita H Nadkarni; Aradhana A Singh; Stacy Colaco; Priya Hariharan; Roshan B Colah; Kanjaksha Ghosh
Journal:  J Clin Lab Anal       Date:  2016-08-26       Impact factor: 2.352

5.  Ethnic and genetic factors of iron status in women of reproductive age.

Authors:  Victor R Gordeuk; Patsy M Brannon
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

Review 6.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

7.  Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.

Authors:  Etheresia Pretorius; Janette Bester; Natasha Vermeulen; Boguslaw Lipinski; George S Gericke; Douglas B Kell
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

8.  Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model.

Authors:  Barbara de Graaff; Lei Si; Amanda L Neil; Kwang Chien Yee; Kristy Sanderson; Lyle C Gurrin; Andrew J Palmer
Journal:  Pharmacoecon Open       Date:  2017-03

Review 9.  Iron and non-alcoholic fatty liver disease.

Authors:  Laurence J Britton; V Nathan Subramaniam; Darrell Hg Crawford
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

10.  EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

Authors:  Graça Porto; Pierre Brissot; Dorine W Swinkels; Heinz Zoller; Outi Kamarainen; Simon Patton; Isabel Alonso; Michael Morris; Steve Keeney
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.